Correlation Between Sunshine Biopharma and Qilian International
Can any of the company-specific risk be diversified away by investing in both Sunshine Biopharma and Qilian International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sunshine Biopharma and Qilian International into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sunshine Biopharma and Qilian International Holding, you can compare the effects of market volatilities on Sunshine Biopharma and Qilian International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sunshine Biopharma with a short position of Qilian International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sunshine Biopharma and Qilian International.
Diversification Opportunities for Sunshine Biopharma and Qilian International
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Sunshine and Qilian is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Sunshine Biopharma and Qilian International Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Qilian International and Sunshine Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sunshine Biopharma are associated (or correlated) with Qilian International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Qilian International has no effect on the direction of Sunshine Biopharma i.e., Sunshine Biopharma and Qilian International go up and down completely randomly.
Pair Corralation between Sunshine Biopharma and Qilian International
Given the investment horizon of 90 days Sunshine Biopharma is expected to under-perform the Qilian International. In addition to that, Sunshine Biopharma is 1.09 times more volatile than Qilian International Holding. It trades about -0.21 of its total potential returns per unit of risk. Qilian International Holding is currently generating about -0.12 per unit of volatility. If you would invest 784.00 in Qilian International Holding on August 28, 2024 and sell it today you would lose (80.00) from holding Qilian International Holding or give up 10.2% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sunshine Biopharma vs. Qilian International Holding
Performance |
| Timeline |
| Sunshine Biopharma |
| Qilian International |
Sunshine Biopharma and Qilian International Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sunshine Biopharma and Qilian International
The main advantage of trading using opposite Sunshine Biopharma and Qilian International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sunshine Biopharma position performs unexpectedly, Qilian International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qilian International will offset losses from the drop in Qilian International's long position.| Sunshine Biopharma vs. Eliem Therapeutics | Sunshine Biopharma vs. HCW Biologics | Sunshine Biopharma vs. Scpharmaceuticals | Sunshine Biopharma vs. Milestone Pharmaceuticals |
| Qilian International vs. Capricor Therapeutics | Qilian International vs. Soleno Therapeutics | Qilian International vs. Bio Path Holdings | Qilian International vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |